Document:

Form of Severance Agreement Amendment

 EXHIBIT 10 (cc) 
 FORM OF SEVERANCE AGREEMENT AMENDMENT 
 This Amendment (this “Amendment”) is entered into
as of the Effective Date by and between Alberto-Culver Company, a Delaware corporation (the “Company”) and
                                     (the
“Executive”) and shall be deemed to be effective on the date the last party signs this Amendment (the “Effective Date”). 
 WHEREAS, the Company and the Executive have entered into the Severance Agreement dated as of                     , as amended as of
                         and as further amended as of January 10, 2006 (the “Severance Agreement”),
pursuant to which the Executive would be entitled to payments and benefits in the event that the Executive’s employment were terminated under the circumstances set forth in the Severance Agreement following, among other things, the approval by
the stockholders of the Company of a transaction that constitutes a Change in Control (as defined in the Severance Agreement); 
 WHEREAS,
the Company and an affiliate of Clayton, Dubilier and Rice, Inc., a Delaware corporation (“CD&R”), may enter into a transaction whereby, among other things, (i) CD&R will acquire approximately 47.5% of the common stock of an
entity that will own the Sally/BSG business of the Company (the “Equity Investment”), and (ii) the Consumer Products and Sally/BSG businesses of the Company will be split into two, separate publicly traded companies (the
“Separation” and, together with the Equity Investment and the other transactions contemplated thereby, the “Transaction”); 
 WHEREAS, the Company intends to treat the Transaction as though it constitutes a Change in Control for the purposes of, and as such term is defined under, the Employee Stock Option Plan of 2003, Employee Stock Option Plan of 1988, 2003
Restricted Stock Plan and 1994 Restricted Stock Plan and accordingly accelerate the vesting of all options to purchase, and restricted shares of, common stock of the Company issued under such plans, including those held by the Executive; 

WHEREAS, in respect of the Company’s Management Incentive Plan and the 1994 Shareholder Value Incentive Plan, the Company intends to treat the
Transaction as though it constitutes a Change in Control (as such term is defined therein) for the participants in such plans, including the Executive; and 
 WHEREAS, the Company and the Executive desire to enter into this Amendment pursuant to which the Company and the Executive agree to amend the Severance Agreement upon the terms and subject to the conditions contained
herein. 
 NOW, THEREFORE, in consideration of the premises and mutual covenants and agreements contained herein, the Company and the
Executive hereby agree as follows: 
 1.    No Deemed Change in Control. The Executive, on behalf of the Executive
and any person claiming through the Executive, and the Company hereby agree that the Transaction, however effected, including any actions taken in respect thereof or in connection therewith, shall not be deemed to constitute a Change in Control for
purposes of the Severance Agreement. This Amendment shall not apply or extend to any right the Executive 

 
may in the future have to any payments or benefits pursuant to the Severance Agreement by reason of the occurrence of a Change in Control unrelated to the
Transaction. 
 2.    Consideration for Amendment. In consideration for entering into this Amendment, the Company
and the Executive agree that in the event of the termination of the Executive’s employment by the Company without Cause or by the Executive for Good Reason during the period commencing on the Effective Date and ending on the second anniversary
of the date of the Separation, the Executive shall be entitled to the payments and benefits set forth on Schedule A hereto. 
 If the
Executive shall be entitled to any payments or benefits pursuant to the Severance Agreement, other than by reason of this Amendment, in connection with a Change in Control unrelated to the Transaction, then the Executive shall not be entitled to any
payments or benefits hereunder. 
 For purposes of this Section 2, the terms Cause and Good Reason shall have the meaning assigned to
such terms in the Severance Agreement, provided that (i) the Effective Date (as defined in this Amendment) shall be substituted for the term “Change in Control” each place such term appears in such definitions and (ii) with
respect to the definition of Good Reason, clause 5 of Section 1(g) shall be deleted in its entirety. 
 3.    Effective Date; Termination of Agreement. This Amendment shall be effective on the Effective Date. This Amendment shall terminate and be of no further force or effect, except in respect of any benefits then
accrued by the Executive hereunder, if and only if (a) the principal agreements related to the Transaction are not signed by the Company and an affiliate of CD&R on or prior to October 31, 2006, or (b) such principal agreements
are terminated prior to the consummation of the Transaction. 
 4.    Scope of Agreement. Nothing in this
Amendment shall be deemed to entitle the Executive to continued employment with the Company or any of its subsidiaries. 
 5.    Notice of Termination. A written notice of the Executive’s termination of employment during the period described in Section 2 by the Company or the Executive, as the case may be, to the other,
shall (i) set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment and (ii) specify the termination date (which date shall be not less than 15 days after the
giving of such notice). The failure by the Executive or the Company to set forth in such notice any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company hereunder or
preclude the Executive or the Company from asserting such fact or circumstance in enforcing the Executive’s or the Company’s rights hereunder. 
 6.    Employment with Affiliates. Employment with the Company shall include, for purposes of this Agreement, employment with any affiliate of the Company, now or hereafter existing.

 7.    Counterparts. This Amendment may be executed in two counterparts, each of which shall be deemed to be an
original and both of which together shall constitute one and the same instrument. 

 8.    Miscellaneous. Capitalized terms not defined herein shall have the
meanings assigned to them in the Severance Agreement. This Amendment and the Severance Agreement constitute the entire understanding and agreement between the Company and the Executive with respect to the subject matter hereof and thereof and
supersede all other prior agreements and understandings between the Executive and the Company with respect to such subject matter. The Severance Agreement, as amended by this Amendment, shall remain in full force and effect in accordance with its
terms. 
 IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by a duly authorized officer of the Company and the
Executive has executed this Amendment as of the dates set forth below. 
  

			
	ALBERTO-CULVER COMPANY
		
	By:	 	  
		 	Name:
		 	Its:
		
		 	Date:                     
	
	EXECUTIVE
	
	  
	
	    Date:                     

 SCHEDULE A TO 
 SEVERANCE AGREEMENT AMENDMENT 
 Lump Sum Payment 
 Within 30 days following the date of termination of the Executive’s employment with the Company in accordance with Section 2 of the Agreement (the “Date
of Termination”), provided that the Company has received a customary release (which release shall extend to all claims against the Company, CD&R and their respective affiliates and agents) signed by the Executive, the Company shall pay to
the Executive a lump sum payment equal to (*) times the Executive’s annual base salary at the Date of Termination from the Company and its affiliated companies, plus (*) times the average of the dollar amount of the
Executive’s actual or annualized (for any fiscal year consisting of less than 12 full months or with respect to which the Executive has been employed by the Company for less than 12 full months) annual bonus, paid or payable, including by
reason of any deferral, to the Executive by the Company and its affiliated companies in respect of the five fiscal years of the Company (or such portion thereof during which the Executive performed services for the Company if the Executive shall
have been employed by the Company for less than such five fiscal year period) immediately preceding the fiscal year in which the Date of Termination occurs. 
 Benefits 
 Medical Insurance Continuation. For a period of 18 months commencing on the Date of Termination, the Company shall
continue to keep in full force and effect all policies of medical insurance with respect to the Executive and his or her dependents with the same level of coverage, upon the same terms and otherwise to the same extent as such policies shall have
been in effect immediately prior to the Date of Termination (such coverage, the “Date of Termination Coverage”) or, if more favorable to the Executive, as provided generally with respect to other peer executives of the Company and its
affiliated companies, and the Company and the Executive shall share the costs of the continuation of such insurance coverage in the same proportion as such costs were shared immediately prior to the Date of Termination, provided, however, that the
Company’s obligation to continue to provide this benefit shall terminate at such time that the Executive commences employment with another employer and becomes eligible to receive medical insurance coverage under an employer-provided plan that
is generally comparable to the Date of Termination Coverage. The coverage provided hereunder shall be applied toward the satisfaction of, and shall not supplement, the Executive’s right to continued coverage under the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended, or any similar state law. 
 Executive Outplacement. The Company will pay for and provide to the
Executive outplacement services with an outplacement firm of Executive’s choosing, provided that the Company shall not be responsible to pay for such services to the extent such services (i) exceed $12,000 or (ii) are provided more
than one year following the Date of Termination. 

 (*) Amount varies for each applicable executive officer as follows: 
  

	 	-	V. James Marino – 2.0 

	 	-	John R. Berschied, Jr. – 1.5 

	 	-	Richard J. Hynes – 1.5 

	 	-	Gary P. Schmidt – 2.0 

	 	-	William J. Cernugel – 2.0 

	 	-	Richard Gerstein – 1.5 

	 	-	Richard Mewborn – 1.5Summary of Compensation Arrangements with Directors

 EXHIBIT 10.14 
 KRONOS INCORPORATED 
 SUMMARY OF COMPENSATION ARRANGEMENTS WITH DIRECTORS 
 The Board of Directors (the “Board”) of Kronos Incorporated (“Kronos”) has approved compensation arrangements for non-employee
directors of Kronos. Pursuant to these arrangements, Kronos compensates non-employee members of the Board through a mixture of cash and equity-based compensation. Each non-employee director receives a quarterly retainer of $1,250 for his services as
a director and $2,750 for each Board meeting attended. Each member of the Audit Committee and Compensation Committee receives $2,000 for all telephonic meetings in excess of 45 minutes and for each committee meeting attended that is not held on the
same day as or the day before a scheduled Board meeting, and $1,000 for each committee meeting which is held on the same day as or the day before a scheduled Board meeting. In addition, the chairman of the Audit Committee of the Board of Directors
receives a quarterly retainer of $1,500 and each member of the Audit Committee receives $500 quarterly. The chairman and members of the Compensation Committee receive a quarterly retainer of $1,500 and $500 respectively and the chairman of the
Nominating Committee receives a quarterly retainer of $500. Kronos also reimburses expenses incurred by non-employee directors to attend Board and committee meetings. 
 Each non-employee director receives an annual stock option grant to purchase shares of Kronos’ common stock at a price equal to the fair market value of Kronos’ common stock on the date of grant, so long as
that director meets the stock ownership guidelines established by the Board. Pursuant to the terms of Kronos’ 2002 Stock Incentive Plan, as amended and restated, the number of shares underlying each such annual option grant is 6,750, subject to
increase (up to a maximum of 7,500 shares annually) or decrease in the discretion of the Board. Pursuant to stock ownership and retention guidelines adopted by the Board, each director is required to purchase a minimum of $100,000 worth of Kronos
stock valued at time of purchase and to maintain this minimum amount of stock ownership throughout his tenure on the Board. New directors have three years after their election to the Board to purchase this minimum amount at the rate of at least
one-third per year. 
 Directors who are also Kronos employees do not receive cash or equity compensation for service on the Board in
addition to compensation payable for their service as employees of Kronos.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]